Everhart Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
21,040
-1,315
-6% -$75.5K 0.08% 141
2026
Q1
$1.36M Buy
22,355
+4,578
+26% +$267K 0.12% 120
2025
Q4
$959K Buy
17,777
+3,982
+29% +$192K 0.09% 162
2025
Q3
$622K Buy
13,795
+4,733
+52% +$221K 0.06% 221
2025
Q2
$419K Sell
9,062
-94
-1% -$4.61K 0.05% 251
2025
Q1
$558K Buy
9,156
+1,591
+21% +$92.7K 0.08% 184
2024
Q4
$428K Buy
7,565
+1,296
+21% +$72.4K 0.09% 209
2024
Q3
$324K Buy
+6,269
New +$294K 0.07% 251
2024
Q2
Sell
-4,333
Closed -$235K 298
2024
Q1
$235K Buy
+4,333
New +$221K 0.07% 245
2023
Q3
Sell
-5,180
Closed -$331K 215
2023
Q2
$331K Buy
5,180
+452
+10% +$30.3K 0.14% 146
2023
Q1
$328K Buy
4,728
+56
+1% +$3.95K 0.15% 125
2022
Q4
$336K Sell
4,672
-1,639
-26% -$124K 0.17% 108
2022
Q3
$448K Buy
6,311
+336
+6% +$24.4K 0.25% 78
2022
Q2
$460K Buy
5,975
+2,887
+93% +$220K 0.28% 81
2022
Q1
$226K Buy
+3,088
New +$207K 0.13% 115

Other funds holding BMY

Everhart Financial Group's BMY Position: Q2 2026 in Review

Everhart Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 5.9% in Q2 2026, selling an estimated $75.5K and leaving 21,040 shares worth $1.21M. The position accounts for 0.08% of the portfolio, ranked #141.

Everhart Financial Group first reported a position in BMY in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.36M in Q1 2026. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Everhart Financial Group held 21,040 shares of Bristol-Myers Squibb worth $1.21M as of Q2 2026.
  • Everhart Financial Group sold 1,315 Bristol-Myers Squibb shares in Q2 2026, an estimated $75.5K.
  • Bristol-Myers Squibb made up 0.08% of Everhart Financial Group's portfolio in Q2 2026, its #141 holding.
  • Everhart Financial Group first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 15 quarters since.
  • Everhart Financial Group's Bristol-Myers Squibb position peaked at $1.36M in Q1 2026.
  • 888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.